By placing an emphasis on early screening as well as new innovations in remote monitoring supported by predictive algorithms to detect infections earlier, health systems can minimize risk to other patients in the hospital. By Peter Ziese, PhD, MD For years, the U.S. has feared the arrival of superbugs, otherwise known as strains of bacteria … Continued
In early June, CMS issued a new memo to surveyors on the importance of reducing cases of Legionella infections. Not long after, the CDC issued a Vital Signs report underlining the bacterium’s risk to patients. The following is an edited Q&A from the CDC Vital Signs Town Hall, “Health Care-Associated Legionnaires’ Disease: Protect Patients With Prevention and Early Recognition.”
The sepsis program in the St. Joseph Hoang network seems to be working. The death rate for all of its hospitals from 2015-2016 has dropped from 15 percent to 12 percent for severe sepsis/shock, and from 12 percent to 9 percent for all sepsis cases.
Between 2006 and 2009, roughly 1.9% of surgical procedures in the United States resulted in SSI complications; however, it’s likely that number is much higher since about 50% of SSIs don’t become evident until after discharge. Estimated costs of SSIs range from $10,443 to $25,546 per infection, although it can cost more than $90,000 to treat an SSI involving a prosthetic joint implant or an antimicrobial-resistant organism.
Testing a new method for limiting the spread of germs and reducing the transmission of disease in the hospital: a handshake-free zone.
Some strains of Candida auris (C. auris) fungusre resistant to all three classes of antifungal drugs. Its spores are extremely durable and can survive on skin and surfaces (such as doorknobs and bedrails) for weeks. Fungal infection can cause a gamut of effects, from mild (runny nose) to severe (death).
In healthcare facilities, cleaning and disinfecting surfaces is essential for reducing the risk of healthcare-associated infections (HAIs). Surfaces, equipment and medical devices found throughout the environment are prone to contamination with healthcare-associated pathogens, many of which can survive on surfaces for prolonged periods and contribute to transmission.
This list is a new tool to ensure R&D responds to urgent public health needs,” said Marie-Paule Kieny, WHO’s assistant director-general for health systems and innovation. Antibiotic resistance is growing, and we are fast running out of treatment options. If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time.
How the U.S. Air Force’s new reliability model focusing on task saturation improved antibiotic stewardship and overall value-based care quickly and cost-effectively.
If you work in healthcare, then you’re probably aware that there’s room for improvement. You’re also probably aware of the deluge of strategies, solutions, recommendations, and guidance on enhancing quality and patient safety—all of which require time, money, equipment, metrics, and manpower you may not have.